Absorption, distribution, metabolism and excretion of an isocitrate dehydrogenase-2 inhibitor enasidenib in rats and humans
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Absorption, distribution, metabolism and excretion of an isocitrate dehydrogenase-2 inhibitor enasidenib in rats and humans
Authors
Keywords
-
Journal
XENOBIOTICA
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2018-01-11
DOI
10.1080/00498254.2018.1425511
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Pathways: IDH2 Mutations--Co-opting Cellular Metabolism for Malignant Transformation
- (2015) E. M. Stein CLINICAL CANCER RESEARCH
- Assessment of the absorption, metabolism and excretion of [14C]pasireotide in healthy volunteers using accelerator mass spectrometry
- (2013) T.-H. Lin et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
- (2013) F. Wang et al. SCIENCE
- The Origin and Evolution of Mutations in Acute Myeloid Leukemia
- (2012) John S. Welch et al. CELL
- A Single Dose Mass Balance Study of the Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Humans Using Accelerator Mass Spectrometry
- (2011) R. A. Graham et al. DRUG METABOLISM AND DISPOSITION
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
- (2010) Patrick S. Ward et al. CANCER CELL
- IDH1andIDH2Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2010) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
- (2010) Stefan Gross et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms
- (2010) A Pardanani et al. LEUKEMIA
- Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms
- (2010) O Kosmider et al. LEUKEMIA
- Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data
- (2010) R Colin Garner Bioanalysis
- Addressing metabolite safety during first-in-man studies using14C-labeled drug and accelerator mass spectrometry
- (2010) Graham Lappin et al. Bioanalysis
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics
- (2008) Graham Lappin et al. Expert Opinion on Drug Metabolism & Toxicology
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search